This STAT report provides an excellent primer on FDA’s drug approval pathways, and the controversies about whether patients can be harmed when FDA standards get too lose. Dr. Diana Zuckerman describes the need for the FDA Commissioner to restore the public’s trust.
Read More »Our Interviews, Blogs & OpEds
FDA’s agenda in limbo as Biden’s nominee stalls in Senate
Fox13, February 9, 2022: President Joe Biden’s pick to lead the Food and Drug Administration has stalled in the narrowly divided Senate, an unexpected setback that could delay decisions on electronic cigarettes and other high-profile health issues. Will all the publicity help Califf get confirmed, given the alternatives?
Read More »The Role of Environmental Regulations in the Fight Against Cancer
NYC NPR, May 10, 2021: President Biden wants a new agency within NIH to “end cancer as we know it.” Dr. Diana Zuckerman explains to NPR that EPA needs to do more to help prevent cancer.
Read More »Can California’s public universities mandate COVID-19 vaccines?
Monterey Herald, April 26, 2021: Dr. Diana Zuckerman and Robert Kaplan address the possibility of mandatory vaccinations at California public colleges and strategies to ensure policies can withstand legal choices.
Read More »Letter to the Editor: Why Expose Children to the Danger of Artificial Turf Fields
Woodbridge Town News, April 22, 2021. Dr. Zuckerman writes about her concerns for children regarding artificial turf. Currently no tests for the impact of turf on human health are required before getting the product on the market.
Read More »